Yesterday, the BioRN Lounge hosted Patrick Maier, Head of the administration office of the Research Campus M2OLIE. As usual it was the occasion for life science companies as well for scientists from our research institutes, to meet and chat about latest news and achievements. The BioRN Lounge is the prime monthly networking event for BioRN members. It is the occasion for exchange, meeting and interaction in a very relaxed atmosphere with some drinks and food. As tradition, an invited speaker from the network presents and discusses with the participants, scientific trends, outbreaking techniques, outstanding research and more.
Through close interdisciplinary cooperation with doctors, scientists, engineers, economists and IT scientists from academic and industrial partners a medical intervention environment for the development of minimally invasive cancer treatments is developed within the M2OLIE Research Campus. The focus is specifically on cancer patients with metastasis, who normally are receiving only a palliative cure. M2OLIE aims at developing the hospital of the future and it can do it only with the support of several bricks from industry (especially SMEs) and academia.
In the current development process, therapeutic procedures in the fields of radiology, nuclear medicine and radiotherapy are to be improved and supplemented by modernised imaging methods, patient-specific radio-pharmaceuticals, robot-based intervention assistants and many more personalised therapeutic procedures.
This variety of innovations, coupled with new examination and treatment methods and patient-specific therapies involves changing the processes both inside and outside the operating room.
Part of the research project also involves optimising these transformed processes through a process management system.
Our next BioRN lounge will be on June 25 as usual in the Kasselhaus by Urban Kitchen and will host the regionally selected startups from the European Health Catapult.
BioRN is a life science research and industry cluster dedicated to the development of cell-specific, molecular and personalised innovative treatments. The BioRN Cluster stands for the development, networking, representation and promotion of the life science region into one of the leading life science clusters in Europe.
The cluster-members include renowned academic research institutions such as the Universities of Heidelberg, the German Cancer Research Center (DKFZ) and the European Molecular Biology Laboratory (EMBL) and big pharmaceutical companies such as AbbVie, Boehringer Ingelheim, GSK, Johnson & Johnson, Merck, Roche, und Sanofi-Aventis, and about 80 small and medium-sized biotech enterprises. Beyond the members registered in the cluster, BioRN gives access to a wider network via partnerships and collaborations.